Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents von Dimopoulos, M.A., Delimpasi, S., Katodritou, E., Vassou, A., Kyrtsonis, M.C., Repousis, P., Kartasis, Z., Parcharidou, A., Michael, M., Michalis, E., Gika, D., Symeonidis, A., Pouli, A., Konstantopoulos, K., Terpos, E., Kastritis, E.

Volltext

Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma von Kastritis, E, Zagouri, F, Symeonidis, A, Roussou, M, Sioni, A, Pouli, A, Delimpasi, S, Katodritou, E, Michalis, E, Michael, M, Hatzimichael, E, Vassou, A, Repousis, P, Christophoridou, A, Kartasis, Z, Stefanoudaki, E, Megalakaki, C, Giannouli, S, Kyrtsonis, M-C, Konstantopoulos, K, Spyroupoulou-Vlachou, M, Terpos, E, Dimopoulos, M A

Volltext

P38 PATIENT‐REPORTED OUTCOMES (PRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH MELFLUFEN AND DEXAMETHASONE (DEX) OR POMALIDOMIDE (POM) AND DEX: ANALYSES FROM THE P... von Schjesvold, F, Ludwig, H, Delimpasi, S, Robak, P, Mateos, M, Sandberg, A, Thuresson, M, Norin, S, Richardson, P, Sonneveld, P

Volltext

The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function von Dimopoulos, M.A., Kastritis, E., Michalis, E., Tsatalas, C., Michael, M., Pouli, A., Kartasis, Z., Delimpasi, S., Gika, D., Zomas, A., Roussou, M., Konstantopoulos, K., Parcharidou, A., Zervas, K., Terpos, E.

Volltext

P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY von Terpos, E, Ntanasis‐Stathopoulos, I, Kastritis, E, Hatjiharissi, E, Katodritou, E, Eleutherakis‐Papaiakovou, E, Verrou, E, Gavriatopoulou, M, Leonidakis, A, Delimpasi, S, Malandrakis, P, Kyrtsonis, M‐C, Papaioannou, M, Symeonidis, A, Dimopoulos, MA

Volltext

P22: A NON‐INTERVENTIONAL, PROSPECTIVE, OBSERVATIONAL STUDY OF RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IXAZOMIB IN REAL‐WORLD SETTINGS IN GREECE; INTERIM RESULTS... von Katodritou, E, Kyrtsonis, MC, Delimpasi, S, Spanoudakis, E, Vassilopoulos, G, Zikos, P, Viniou, N, Kaiafa, G, Papathanasiou, M, Pappa, V, Michalis, E, Adamopoulos, I, Kokoviadou, K, Tsirakis, G, Poziopoulos, C, Terpos, E

Volltext

P916: COEXISTENCE OF ≥2 HIGH‐RISK MOLECULAR ABNORMALITIES SUPERVENES THE PROGNOSTIC VALUE OF THE REVISED INTERNATIONAL STAGING SYSTEM FOR MYELOMA: REAL‐WORLD DATA ANALYSIS FROM THE... von Katodritou, E., Dalampira, D., Triantafyllou, T., Gavriatopoulou, M., Delimpasi, S., Pouli, A., Papadopoulou, T., Verrou, E., Sevastoudi, A., Tsirou, K., Katsika, L., Douganiotis, G., Karampatzakis, N., Metallinou, T.‐E., Palaska, V., Kotsopoulou, M., Lalayianni, C., Kyrtsonis, M.‐C., Spanoudakis, E., Maltezas, D., Chatzivasili, A., Dimopoulos, M.‐A., Terpos, E., Kastritis, E.

Volltext

PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF SUBCUTANEOUS CEVOSTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY M... von Delimpasi, S., Quach, H., Cavo, M., Ho, P. J., Lee, C. H.‐S., Santoro, A., Schots, R., Vlummens, P., Yoon, D. H., Yoon, S.‐S., Santos, C. D., Samineni, D., Huang, J., Wehrman, K., Patil, U., Sheikh, S., Dimopoulos, M. A.

Volltext

CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB VERSUS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF THE PHASE 3 CANDOR STUDY BY NUMBER... von Quach, H., Nooka, A., Samoylova, O., Venner, C.P., Facon, T., Spencer, A., Usmani, S.Z., Weisel, K., Mateos, M., Kim, K., Grosicki, S., Suzuki, K., Delimpasi, S., Obreja, M., Zahlten-Kumeli, A.

Volltext

ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: ICARIA-MM SUBGROUP ANALYSIS von Capra, M.E.Z., Beksac, M., Richardson, P.G., Unal, A., Corradini, P., Delimpasi, S., Gulbas, Z., Mikala, G., Neylon, A., Symeonidis, A., Bringhen, S., Moreau, P., Velde, H.V., Campana, F., Guennec, S.L., Spicka, I.

Volltext

Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study von Terpos, E., Symeonidis, A., Delimpasi, S., Zamagni, E., Katodritou, E., Rivolti, E., Kyrtsonis, M., Fotiou, D., Kanellias, N., Migkou, M., Roussou, M., Gavriatopoulou, M., Hatjiharissi, E., Cavo, M., Dimopoulos, M.

Volltext

Bradycardia during induction therapy with all-trans retinoic acid (ATRA) von Karakatsanis, S, Vardaka, M, Giannoulia, P, Apostolidis, J, Delimpasi, S

Volltext

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial von Moreau, Philippe, Dimopoulos, Meletios-Athanasios, Mikhael, Joseph, Yong, Kwee, Capra, Marcelo, Facon, Thierry, Hajek, Roman, Špička, Ivan, Baker, Ross, Kim, Kihyun, Martinez, Gracia, Min, Chang-Ki, Pour, Ludek, Leleu, Xavier, Oriol, Albert, Koh, Youngil, Suzuki, Kenshi, Risse, Marie-Laure, Asset, Gaelle, Macé, Sandrine, Martin, Thomas, Moreau, Philippe, Dimopoulos, Meletios-Athanasios, Mikhael, Joseph, Yong, Kwee, Capra, Marcelo, Facon, Thierry, Hajek, Roman, Spicka, Ivan, Baker, Ross, Kihyun, Kim, Martinez, Gracia, Chang-Ki, Min, Pour, Ludek, Leleu, Xavier, Oriol, Albert, Youngil, Koh, Suzuki, Kenshi, Martin, Tom, Quach, Hang, Lim, Andrew, Crowther, Helen, Sia, Hanlon, Hulin, Cyrille, Mohty, Mohamad, Mikala, Gabor, Nagy, Zsolt, Reinoso Segura, Marta, Rosinol, Laura, Yagci, Munci, Turgut, Mehmet, Garg, Mamta, Parmar, Gurdeep, Augustson, Brad, Castro, Nelson, Crusoe, Edvan, Pika, Tomas, Delimpasi, Sosana, Ishizawa, Kenichi, George, Anup, Konstantinova, Tatiana, De La Rubia, Javier, Sung-Hyun, Kim, Maiolino, Angelo, Reiman, Anthony, LeBlanc, Richard, Ito, Shigeki, Tanaka, Junji, Luchinin, Alexander, Kryuchkova, Irina, Martinez, Joaquin, Shustik, Jesse, Karlin, Lionel, Symeonidis, Anargyros, Egyed, Miklos, Petrini, Mario, Cavo, Michele, Uchiyama, Michihiro, Blacklock, Hilary, Arat, Mutlu, Griffin, James, Hunter, Hannah, Buck, Tonda, Anagnostopoulos, Achilles, Konstantopoulos, Konstantinos, Masszi, Tamas, Bringhen, Sara, Gamberi, Barbara, Kawano, Yawara, Jin Seok, Kim, Ozdogu, Hakan, Ozkalemkas, Fahir

Volltext

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, ph... von Richardson, Paul G, Beksac, Meral, Liberati, Anna Marina, Galli, Monica, Lindsay, Jindriska, White, Darrell, Facon, Thierry, San Miguel, Jesus, Sunami, Kazutaka, O'Gorman, Peter, Sonneveld, Pieter, Robak, Pawel, Schey, Steve, Yu, Xin, Bensmaine, Amine, Zaki, Mohamed, Abildgaard, Niels, Adler, Howard, Altuntas, Fevzi, Arce-Lara, Carlos, Aydin, Yildiz, Basu, Supratik, Battini, Ramakrishna, Beeker, Thaddeus, Ben-Yehuda, Dina, Boccia, Ralph, Cavo, Michele, Chantry, Andrew, Chaudhry, Arvind, Corso, Alessandro, De Arriba, Felipe, Delimpasi, Sosana, Desjardins, Pierre, Dhakal, Binod, Di Bartolomeo, Paolo, Dürig, Jan, Engelhardt, Monika, Esteves, Graca, Flogegard, Max, Gabrail, Nashat, Gamberi, Barbara, Garrison, Mitchell, Gisslinger, Heinz, Goldschmidt, Hartmut, Gressot, Laurent, Grosicki, Sebastian, Hanna, Wahid, Henriques Bernardo, Maria Manuela, Hermann, Robert, Holden, Viran, Huben, Marianne, Janakiram, Murali, Jenner, Matthew, João, Cristina, Jurcyszyn, Artur, Kalayoğlu Beşişik, Sevgi, Kambhampati, Suman, Karadoğan, Ihsan, Khojasteh, Ali, Kirkel, Dean, Komarnicki, Mieczyslaw, Lauri, Birgitta, Leleu, Xavier, Matsue, Kosei, Mendeleeva, Larisa, Miller, Carole, Mohrbacher, Ann, Müldür, Ercan, Naassan, Anthony, Nahi, Hareth, Nair, Rajesh, O'Dwyer, Mike, Openshaw, Thomas, O'Rourke, Timothy, Osswald, Michael, Overton, Lindsay, Pavic, Michel, Pierola, Ana Alfonso, Rabin, Neil, Ramasamy, Karthik, Rambaldi, Alessandro, Rodriguez, Paula, Röllig, Christoph, Rosenblatt, Jacalyn, Rosenbluth, Jonathan, Salomo, Morten, Samoylova, Olga, Sastre Moral, Jose, Shafeek, Salim, Shinagawa, Atsushi, Sleckman, Bethany, Smith, Clay, Suzuki, Kenshi, Takezako, Naoki, Teke, Hava Üsküdar, Vapaatalo, Mirja, Vassilopoulos, George, Verma, Amit, Wang, Xiang Sean, Yağci, Munci

Volltext

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial von Gay, Francesca, Weisel, Katja Christina, Goldschmidt, Hartmut, Maisnar, Vladimir, Moreau, Philippe, Pluta, Agnieszka, Chng, Wee-Joo, Kaiser, Martin, Zweegman, Sonja, Spencer, Andrew, Skacel, Tomas, Palumbo, Antonio, Labotka, Richard, Fantl, Dorotea, Horvath, Neomi, Lee, Cindy, Taylor, Kerry, Spencer, Andrew, Agis, Hermine, Zojer, Niklas, Offner, Fritz, Wu, Ka Lung, Zanella, Karla, Capra, Marcelo, Araújo, Sérgio, Gregora, Evzen, Hajek, Roman, Maisnar, Vladimir, Scudla, Vlastimil, Spicka, Ivan, Abildgaard, Niels, Andersen, Niels, Jensen, Bo Amdi, Plesner, Torben, Salomo, Morten, Svirskaite, Asta, Moreau, Philippe, Goldschmidt, Hartmut, Schieferdecker, Aneta, Zeis, Matthias, Klein, Stefan, Reimer, Peter, Hoffmann, Martin, Kyrtsonis, Mary-Christine, Anagnostopoulos, Achilleas, Illés, Árpád, Borbényi, Zita, Mikala, Gabor, Dally, Najib, Horowitz, Netanel, Gutwein, Odit, Nemets, Anatoly, Vaxman, Iuliana, Trestman, Svetlana, Preis, Meir, Rossi, Giuseppe, Liberati, Anna Marina, Bosi, Alberto, Nakaseko, Chiaki, Matsumoto, Morio, Nagai, Hirokazu, Sunami, Kazutaka, Chou, Takaaki, Akashi, Koichi, Eom, Hyeon Seok, Min, Chang Ki, Yoon, Sung Soo, Kim, Kihyun, Vellenga, Edo, Grosicki, Sebastian, Pluta, Andrzej, Robak, Tadeusz, Bergantim, Rui, Goh, Yeow Tee, McDonald, Andrew, Rapoport, Bernado, Álvarez Rivas, Miguel Angel, De Arriba de La Fuente, Felipe, Mateos, Maria Victoria, Oriol Rocafiguera, Albert, San Miguel, Jesús, Alegre-Amor, Adrian, Axelsson, Per, Carlson, Kristina, Stromberg, Olga, Hansson, Markus, Liu, Ta-Chih, Huang, Shang-Yi, Unal, Ali, Goker, Hakan, Sonmez, Mehmet, Korenkova, Sybiryna, Oakervee, Heather, Sati, Hamdi, Benjamin, Reuben, Garg, Mamta, Cook, Gordon, Jenner, Matthew, Berryman, Robert, Janakiram, Murali

Volltext

EE73 Ocean (OP-103): Patients with Relapsed/Refractory Multiple Myeloma Treated with Melflufen Plus Dexamethasone or Pomalidomide Plus Dexamethasone - a Resource Utilization Analys... von Hellem Schjesvold, F., Ludwig, H., Delimpasi, S., Robak, P., Mateos, M.V., Sandberg, A., Obermüller, J., Norin, S., Richardson, P.G., Sonneveld, P.

Volltext

820P Second primary malignancies and disease transformation in symptomatic patients with Waldenstrom’s macroglobulinemia: Outcomes of a population-based analysis von Spiliopoulou, V., Ntanasis-Stathopoulos, I., Kyrtsonis, M-C., Symeonidis, A., Hatjiharissi, E., Giannakoulas, N., Spanoudakis, E.G., Delimpasi, S., Michali, E., Michael, M.D., Vassou, A., Iskas, M., Pouli, A., Vervessou, E., Christoulas, D., Katodritou, E., Terpos, E., Kastritis, E., Dimopoulos, M.A.C., Gavriatopoulou, M.

Volltext

Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies von Zagouri, Flora, Kastritis, Efstathios, Zomas, Athanasios, Terpos, Evangelos, Katodritou, Eirini, Symeonidis, Argiris, Delimpasi, Sosana, Pouli, Anastasia, Vassilakopoulos, Theodoros P., Michalis, Eurydiki, Giannouli, Stavroula, Kartasis, Zafiris, Christoforidou, Anna, Kokoviadou, Kiriaki, Hatzimichael, Eleftheria, Gika, Dimitra, Megalakaki, Catherine, Papaioannou, Maria, Kyrtsonis, Marie‐Christine, Konstantopoulos, Kostas, Dimopoulos, Meletios A.

Volltext

Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy von Kastritis, Efstathios, Kyrtsonis, Marie-Christine, Morel, Pierre, Gavriatopoulou, Maria, Hatjiharissi, Evdoxia, Symeonidis, Argirios S, Vassou, Amalia, Repousis, Panagiotis, Delimpasi, Sossana, Sioni, Anastasia, Michalis, Evrydiki, Michael, Michail, Vervessou, Elina, Voulgarelis, Michael, Tsatalas, Costantinos, Terpos, Evangelos, Dimopoulos, Meletios A

Volltext

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group von Katodritou, Eirini, Terpos, Evangelos, Delimpasi, Sossana, Kotsopoulou, Maria, Michalis, Eurydiki, Vadikolia, Chrysanthi, Kyrtsonis, Marie-Christine, Symeonidis, Argiris, Giannakoulas, Nikolaos, Vadikolia, Chrissa, Michael, Michalis, Kalpadakis, Christina, Gougopoulou, Theodora, Prokopiou, Chrystalla, Kaiafa, Georgia, Christoulas, Dimitrios, Gavriatopoulou, Maria, Giannopoulou, Evlampia, Labropoulou, Vasiliki, Verrou, Evgenia, Kastritis, Efstathios, Konstantinidou, Pavlina, Anagnostopoulos, Achilles, Dimopoulos, Meletios A.

Volltext